KRISTIN VANDOMELEN: Open Payments
NPI 1710117122 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 5 companies in 2025. Trend: 2023 $59 · 2024 $60 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Novo Nordisk Inc | 4 | $76 |
| Gilead Sciences, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $37 |
| Amgen Inc. | 1 | $17 |
Products named: UBRELVY, GEMTESA, Biktarvy, QULIPTA, EVENITY.
Industry payments across OR — which companies pay providers there.
